Cytogen Corp expand clinical trial cancer image technology. It study anticipate begin mid year. It phase human test begain October. The technology us monocloncal antibody tag radioisotope diagnose colorectal cancer cancer types. It preliminary study reveal antibody combination tolerate patient studied. Reuter 